IMCAS website has a fresh new look! Explore our redesigned website. We're here to help you navigate the new features and welcome your feedback at contact@imcas.com.
English
Español
Français
Português
Русский
简体中文
09:15
BSL - Evolution of mechanical adipose tissue-derived stromal cell isolations with Sharp Blade systems
09:45
Lutronic - Hollywood spectra and non-invasive collagen synthesis - From science to daily practices
10:30
Aptos - Small solution for big problems. P(LA/CL) threads with HA composition
11:30
Lumenis - Discover SmoothGlo™: A breakthrough skin rejuvenation treatment, setting the new standard for aesthetic results
11:45
SNJ - Finebeam Dual Q-switched and Long pulsed Dual functions in one Platform Nd:YAG technological innovation presents optimal skin improvement
13:30
Lutronic - Personal experience with microneedle RF device Lutronic Genius treating acne scars
13:45
Asterasys - Individualization of HIFU treatments using advanced techniques and pen type applicator
14:30
Skin Tech Pharma - RRS HA® Long Lasting - New Skin Builder - 7 Points technique
14:45
Skin Tech Pharma - RRS HA® Long Lasting - New aesthetic challenge - Skin Premium 3D rejuvenation
15:15
Vida Pharma - Buttock augmentation with hyaluronic acid fillers: a new market approach
16:00
Galderma - Effectiveness of cheek treatment after providing a treatment guide to help choose between hyaluronic acid filler HA-VOL or HA-LYF: the CHEEKY Study
16:15
Galderma - Extension study on safety and effectiveness of PLLA for correction of nasolabial folds after changes in reconstitution and injection procedures
16:30
Galderma - Liquid abobotulinumtoxinA for glabellar line treatment: post hoc analysis of duration of effect and subject satisfaction Phase III study data
16:45
Galderma - Ready-to-use liquid abobotulinumtoxinA for moderate-to-severe glabellar lines: pooling of two double-blind, randomized, controlled Phase III studies
17:15
APS SRL - Clinical study on the effectiveness and tolerability of preformed growth factors vehiculated through ionophoresis on patients with androgenetic alopecia and telogen effluvium
Discover IMCAS Academy
Need assistance?